Kisunla, also known by its generic name donanemab-azbt, is a medication prescribed for Alzheimer’s disease in adults. It is a biologic drug that falls under the drug class of beta amyloid-directed antibodies. Unlike some medications, Kisunla is not available in a biosimilar version. This article aims to provide a detailed overview of Kisunla dosages, including
Alzheimers
When it comes to taking Kisunla, it is important to be aware of the precautions associated with this medication. Kisunla comes with a boxed warning, which is a serious cautionary alert issued by the Food and Drug Administration (FDA). This warning is meant to inform both healthcare providers and patients about potential dangerous side effects
When it comes to the brand-name solution Kisunla (donanemab-azbt) for Alzheimer’s disease treatment, the cost can vary depending on several factors. These factors include your treatment plan, insurance coverage, the cost of healthcare professional visits for the infusion, and the availability of a savings program for Kisunla. It is important to understand that the cost